fda compounding glp-1 warning letters october 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounded "semaglutide" is not FDA-approved
Description
The temporary program will provide coverage of three GLP-1 drugs used for weight reduction and weight management to eligible Medicare beneficiaries.
Proper injection technique directly impacts medication absorption and comfort during GLP-1 therapy
Safe and simple ways to dispose of weight-loss injection needles like Ozempic, Wegovy, and Zepbound at home and the hazards of loose needles.
GLP-1 receptor agonists are prescribed off-label for weight loss in non-diabetic adults with obesity or overweight status plus weight-related comorbidities
(the intracellular action meCHAnism of incretin) () 1
